Invitae

About

Invitae is a medical genetics company that bring comprehensive genetic information into mainstream medicine to improve healthcare.

San Francisco,California,United States
501 - 1000
http://invitae.com

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $29.55M
Industries: Biotechnology,Genetics,Health Care
Founded date: Jan 1, 2010
Number Of Employee: 501 - 1000
Operating Status: Active
Stock Symbol: nyse:NVTA
Legal Name: Invitae Corporation
Also Known As: Locus Development Inc

Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people.

Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today.

What’s our plan? It takes three steps:

--Make genetic testing more affordable and accessible than ever before.
--Build a secure and trusted genome management infrastructure.
--Design a new global community for sharing genetic information to advance science and medicine.

Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$2.09B

Invitae has raised a total of $2.09B in funding over 2 rounds. Their latest funding was raised on Apr 5, 2021 from a Post-IPO Debt round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Apr 5, 2021	Post-IPO Debt	$1.15B	1	SoftBank	—	Detail
Jan 20, 2021	Post-IPO Equity	$460M	—	—	—	Detail
Apr 1, 2020	Post-IPO Equity	$184M	—	—	—	Detail
Feb 12, 2015	IPO	$102M	—	—	—	Detail
Oct 13, 2014	Series F	$120M	14	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

1

0

Invitae has made 1 investments. Their most recent investment was on Oct 2, 2018, when Lingokids raised $6M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Oct 2, 2018 Lingokids	Series A	$6M	Children	—

Investors

Number of Lead Investors

Number of Investors

1

16

Invitae is funded by 16 investors. SoftBank and Casdin Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
SoftBank	Yes	Post-IPO Debt
Casdin Capital	—	Series F
Decheng Capital	—	Series F
Deerfield Capital Management	—	Series F
Genesys Capital	—	Series F
Genomic Health	—	Series F
J.P. Morgan Securities Inc.	—	Series F
OrbiMed	—	Series F
Perceptive Advisors	—	Series F
Redmile Group	—	Series F

Employee Profiles

Number of Employee Profiles

29

Invitae has 29 current employee profiles, including Employee Mike Issac

Employee

Employee

Executive

Employee

Employee

Acquisition

Invitae has acquired 14 organizations. Their most recent acquisition was AltaVoice on Jan 6, 2017. They acquired AltaVoice for 0.

Date Company Name	Industry	Acquisition Type	Price
Jan 6, 2017 AltaVoice	Biotechnology	acquisition	—	Detail
Jun 12, 2017 CancerGene Connect	Genetics	acquisition	—	Detail
Jul 31, 2017 CombiMatrix	Biotechnology	acquisition	$ 33M	Detail
Jul 31, 2017 Good Start Genetics	Biotechnology	acquisition	$ 24.30M	Detail
Jan 17, 2019 Singular Bio	Biotechnology	acquisition	—	Detail